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Abstract
Objective—To assess the effect of delayed cord clamping (DCC) versus immediate cord
clamping (ICC) on intraventricular hemorrhage (IVH), late onset sepsis (LOS), and 18-month
motor outcomes in preterm infants.
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Study design—Women (n=208) in labor with singleton fetuses (≤ 32 weeks gestation) were
randomized to either DCC (30–45 seconds) or ICC (< 10 seconds). The primary outcomes were
IVH, LOS, and motor outcomes at 18–22 months corrected age. Intention-to-treat was used for
primary analyses.
Results—Cord clamping time was 32 ± 16 seconds (DCC) vs. 6.6 ± 6 (ICC). Infants in the DCC
and ICC groups weighed 1203 ± 352 grams and 1136 ± 350 and mean gestational age was 28.3 ±
2 and 28.4 ± 2 weeks respectively. There were no differences in rates of IVH or LOS between
groups. At 18–22 months, DCC was protective against motor scores below 85 on the Bayley
Scales of Infant Development-III (Bayley-III) (OR 0.32, 95% CI 0.10 – .0.90, p = 0.03). There
were more women with preeclampsia (PEC) in the ICC group (37% vs 22%, p = 0.02) and more
women in the DCC group with premature rupture of membranes/ preterm labor (PROM/PTL)
(54% vs 75%, p = 0.002). PEC halved the risk of IVH (OR 0.50, 95% CI 0.2 – 1.0) and
PROM/PTL doubled the risk of IVH (OR 2.0, 95% CI 1.2–4.3).
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Conclusions—Although DCC did not alter the incidence of IVH or LOS in preterm infants, it
improved motor function at 18–22 months corrected age.
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When cord clamping is delayed at birth or the cord is milked, infants receive a placental
transfusion of 10 to 15 mL/kg during the first few minutes of life.1 This additional blood
improves hemodynamic stability and may reduce the risk of intraventricular hemorrhage
(IVH)2, 3 and the vulnerability of infants to inflammatory processes.4–6 This blood also
contains stem cells that are important in repairing tissue and building immunocompetence.7
Recently, the American College of Obstetricians and Gynecologists recommended delayed
cord clamping (DCC) for preterm infants when feasible but the current obstetrical practice at
birth remains immediate clamping.8–10
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Prior studies on DCC in preterm infants have shown benefits without harm. The most recent
meta-analysis by Rabe et al on infants under 37 weeks found reduced rates of neonatal
transfusion (OR 0.61, 95% CI 0.46 – 0.81, p < 0.0005), less IVH (OR 0.59, 95% CI 0.41 –
0.85, p < 0.005) and no difference in late onset sepsis (LOS).11 Backes et al reported similar
findings in infants less than 32 weeks adding a finding of lower mortality (OR 0.42, 95% CI
0.19–0.95, p =0.04).12 Previously, we reported reduced rates of IVH and LOS13 and some
protection of very low birth weight (VLBW) male infants against motor disability at 7
months corrected age.14

Author Manuscript

The current randomized controlled trial prospectively tested the effects of DCC for 30 to 45
seconds followed by one cord milking with the aim of confirming our prior work and
providing long term follow-up. Our a priori hypotheses were that DCC would reduce the
incidence of IVH, LOS, and result in better motor function at 18–22 months.

Methods

Author Manuscript

This trial was conducted at Women and Infants’ Hospital (WIH) of Rhode Island with WIH
and the University of Rhode Island Institutional Review Board approval. Thirty patients
(14%) were enrolled prior to trial registration, but no data were examined prior to trial
registration. An independent data safety and monitoring committee reviewed the data after
36, 100, and 150 infants were randomly assigned and identified no concerns. Women with a
singleton pregnancy estimated at 24 to 31.6 weeks gestation by obstetrical evaluation were
eligible irrespective of mode of delivery. Exclusion criteria included multiple gestation,
prenatally diagnosed major congenital anomalies, severe or multiple maternal illnesses, and
mothers who were at risk for loss to follow-up. Blocked stratified randomization of subjects
born before or after 28 weeks to the immediate cord clamping (ICC) or DCC group was
used to assign the groups with a prespecified equal probability. Sequenced and sealed
envelopes identifying the stratification and group assignment on cards were prepared by a
statistician not involved in the trial and kept in a locked file box in the Labor and Delivery
Unit. All participants were screened, consented and enrolled by study nurses following
written informed consent. Study nurses randomized mothers based on the next study card
designation when women went into active labor.
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Women were randomized to either DCC followed by one milking of the cord (intervention
group) or ICC (control group). For all births, research personnel used a stopwatch to record
the exact timing of cord clamping. Once the cord was cut, the infant was moved to the
warmer and placed on a warming mattress. All subsequent care was managed by the
neonatal team in attendance. For the DCC group, the obstetrician placed the infant in a
sterile warm towel or blanket and held the infant approximately 10–15 inches below the
mother’s introitus at vaginal delivery or below the level of the placenta at cesarean delivery.
Care was taken to avoid traction on the cord. Suctioning was at the discretion of the
obstetrician. The research nurse, using a stopwatch, counted out the time elapsed in ten
second intervals to the obstetrician. At 30 to 45 seconds, the obstetrician was asked to milk
the infant’s cord once then clamp and cut the umbilical cord. If unable to carry out the DCC
protocol as planned, the cord was milked quickly 2 to 3 times before clamping when
possible (n = 11). In the event that the timing of the cord clamping was less than 30 seconds
with no cord milking and the baby was randomized to the DCC group, a protocol violation
report was completed and the infant remained in the DCC group for primary intention-totreat analyses (n = 15). The ICC group received routine care of cord clamping in less than 10
seconds. Cranial ultrasounds were obtained at one, seven, and 28 days. Formal
developmental follow-up assessments at seven and 18 – 22 months corrected age were
completed.
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IVH was defined as bleeding in the brain assessed by cranial ultrasound readings using the
criteria of Papile.15 The staff pediatric radiologist read the ultrasound initially followed by a
collaborating pediatric radiologist masked to the infants’ grouping. Discrepancies were
adjudicated by consensus through discussion among radiologists. LOS was defined as a
positive bacterial blood culture after 72 hours of age. The Bayley Scales of Infant
Development Motor Scale (Bayley-III) was used to assess cognitive, language and motor
function.16 The motor composite score and subscores for fine motor and gross motor skills
were analyzed. The Bayley-III composite score has a mean ± SD of 100 ±15.
Secondary outcome variables included safety variables (Apgar scores, initial temperature
upon admission, peak bilirubin in the first week of life), initial blood pressure, initial
hematocrit, necrotizing enterocolitis (NEC), bronchopulmonary dysplasia (BPD), and
retinopathy of prematurity (ROP) as diagnosed by attending clinicians. NEC was diagnosed
based on Bell criteria, BPD was defined as requiring oxygen therapy at 36 weeks
postmenstrual age or death, and ROP was identified by an ophthalmologist per routine eye
examinations.
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The study could not be blinded because of the obvious nature of the intervention. Our
institutional policy requires the presence of a neonatology staff member at delivery because
of early gestation. Staff who attended each birth were asked not to reveal the infant’s
grouping in the infant’s medical records. Personnel collecting on-going clinical data and the
follow-up staff completing the developmental assessment remained blinded.
The power analysis was based on our Phase 1 study13 and expected treatment effects for a
simple test of proportions of group differences (ICC vs. DCC) for the primary study
outcome of IVH. We conservatively estimated an odds ratio of about 2.5 for this new study,
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which yielded a sample size of 92 per group for power of 0.80. Given the need for followup, we allowed for an attrition rate of about 15%, resulting in a total baseline sample size of
212 VLBW infants. The use of block-stratified randomization enhanced the study design
sensitivity.
The diagnoses of preterm labor (PTL) and premature rupture of the membranes (PROM)
were not discrete among the subjects. Consequently, we combined them into one variable
PROM/PTL that represented women who had either diagnoses. Both conditions can be
associated with intrauterine inflammation.17

Author Manuscript

Data analyses included Pearson Chi-Square tests, t-tests, Wilcoxon rank-sum tests for nonnormally distributed variables, and multiple logistic and linear regression models to adjust
for possible confounders. No correction was used to adjust for multiple tests. For outcomes,
odds ratios were calculated along with appropriate 95% confidence intervals. Primary
analyses were conducted using intention-to-treat. Post-hoc sensitivity analyses using actual
treatment were indicated and performed to assess the robustness of the findings.18

Results

Author Manuscript

Pregnant women (n=211) between 24 and 31.6 weeks gestation were randomized from May
15, 2008, through August 31, 2014 (Figure 1; available at www.jpeds.com). There were 107
infants in the ICC and 104 in the DCC group. Three infants were withdrawn (congenital
anomalies and birth injury which precluded randomization), leaving a total sample of 208
mother- infants dyads. Maternal and infant demographic and clinical variables were
analyzed for the remaining randomized subjects. Neonatal morbidities were analyzed for the
199 infants who survived the Neonatal Intensive Care Unit (NICU) course. There were 24
(12%) protocol violations (9 ICC and 15 DCC group) that remained in their assigned groups
for primary intention-to-treat analyses. One infant died after discharge, five refused followup, and 32 were lost to follow-up. At 18–22 months, 82% (DCC) and 81% (ICC) were
evaluated.

Author Manuscript

Table I shows the maternal and neonatal demographics and clinical characteristics. There
were significantly more women with PROM/PTL in the DCC group in both cohorts, and
more women with PEC at admission in the ICC group. There were no significant differences
between the two groups in parity, public insurance, marital status, antenatal steroids,
intrauterine growth restriction or cesarean delivery rate. Per protocol, cord clamping time
was significantly increased in the infants in the DCC group. All other neonatal variables,
including those used to assess protocol safety, did not differ between groups. There were no
differences in numbers of infants who received phototherapy, days of phototherapy, delivery
room resuscitation, or Score for Neonatal Acute Physiology (SNAP) scores at 12 hours of
age (data not shown).
Table II shows that in initial analysis of the cohort there were no significant differences in
the primary outcome variables of IVH and LOS at NICU discharge. Nine infants (3 = DCC
and 6 = ICC) were removed from this analysis as they died before discharge. For each week
of gestational age (GA) gained, the odds of IVH were reduced by 15% (OR .85, 95% CI .7
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– .98) (data not shown). The diagnosis of PROM/PTL in the mother doubled the risk of IVH
(OR 2, 95% CL 1, 4.3), and PEC lowered the risk by one-half (OR .5, 95% CL .2–1). When
both PEC and PROM/PTL were included in a regression model, they balanced each other
out leaving only GA to predict IVH.
Infants with LOS were younger at birth (mean of 26.7 versus 28.7 weeks, p <0.001); 22% (n
= 15) of infants less than 28 weeks had LOS, and 9% (12) of those greater than 28 weeks
had LOS (p = 0.008). Using regression analyses to predict LOS, we found no effect of PEC
or PROM/PTL on LOS. Only GA predicted LOS with younger infants more affected as
expected (OR .63, 95% CI .5 – .79) (data not shown).

Author Manuscript

There were no differences between the groups at seven-month corrected age assessments
(data not shown). At 18–22 months, primary bivariate analysis by intention-to-treat showed
no significant differences between groups on the Bayley-III motor assessment (Table II).
We completed sensitivity analyses because of the 12% rate of protocol violations and the
symmetrically unequal groups on two major confounding variables. There were no
differences between the two groups of infants with protocol violations on the 1- or 5-minute
Apgar scores (data not shown). Using sensitivity analyses, no differences were found in the
incidence of IVH or LOS (Table II). However, more than twice the number of children who
received ICC scored less than 85 on the Bayley-III motor composite versus those who
received DCC using the bivariate sensitivity analysis.
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In Figure 2, multiple logistic regression analysis shows that if the child had DCC, the child’s
chance of scoring less than 85 on the Bayley-III motor composite score was reduced by 68%
after adjusting for known risk factors using intention-to-treat analysis and 76% using actual
treatment (sensitivity analysis). If the mother had a history of clinical chorioamnionitis, her
infant had 4-fold greater odds of scoring below 85. If the child had IVH, he had 6-fold
increased odds of scoring less than 85 on the motor composite. Having public insurance
more than doubled the child’s chances of scoring less than 85 on the motor composite.
Scores under 70 points were predicted only by GA in all models (data not shown). The last
bar represents the sensitivity analysis showing that the effect of DCC on Bayley-III motor
scores less than 85 was stronger among the infants who actually received the intervention.

Author Manuscript

Eligible women delivering < 32 weeks (n = 121) not enrolled differed from the women
randomized within the study on antenatal steroid use (ANS) (93% vs 98%, p = 0.009), rates
of one ANS dose only (73% vs 27%, p <0.001), MgSO4 (13% vs 39%, p = <0.0001), hours
of PROM (60% vs 76%, p = 0.002), chorioamnionitis (5% vs 15%, p = 0.0001), PROM
(30% vs 39% p = 0.03), and births by cesarean (51% vs 66%, p = 0.005). Infants of these
women differed from enrolled infants only on median temperatures on NICU admission
(median 36.3 vs 36.5 degrees centigrade, p = 0.02). There were no differences in the
incidence of IVH (18% vs 25%, p = 0.35).

Discussion
This study of VLBW preterm infants randomized to ICC versus DCC (plus milking) reports
the motor outcomes at 18–22 months corrected age. Unbalanced groups with respect to two
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powerful confounders, PEC and PROM/PTL, complicated the analyses. Nevertheless, the
main finding from our study was that a brief delay in cord clamping was associated with
better motor outcomes at 18–22 months when controlling for NICU morbidities and public
health insurance as proxy for socioeconomic status.
The findings did not support our hypothesis that infants with DCC would have less IVH or
LOS. Exploration of the data showed that conditions antecedent to birth had a powerful
confounding effect on IVH. PEC, higher in the ICC group, reduced an infant’s odds of
experiencing IVH by half. PROM/PTL, more prevalent among mothers randomized to the
DCC group, doubled the infant’s odds of experiencing IVH. Recent research suggests
probable mechanisms of action for the two opposite effects.19, 20

Author Manuscript

The mechanism for protection against IVH in infants born to women with PEC is not
known. It is possible that intrauterine “stress” from maternal PEC protects the preterm infant
against IVH by “maturing” the brain blood vessels especially those in the fragile germinal
matrix (GM).20 Before 32 weeks gestation, high levels of vascular endothelial growth factor
(VEGF) and angiopoietin stimulate the rapid growth in the vascular GM. Like
indomethacin, PEC in the mother may suppress these important growth factors in the fetus
allowing more time for the pericytes to cover and protect the vessels.20 Slowing the rapid
growth may reduce the chance of rupture of these vessels into the GM when the infant is
stressed by preterm birth.20

Author Manuscript

Conversely, PROM/PTL increased the infant’s chance of IVH after preterm birth twofold
through inflammatory processes. There is robust evidence linking IVH with intrauterine
inflammation.19, 21, 22 Inflammation with and without infection is known to cause release of
pro-inflammatory cytokines into the amniotic fluid and surrounding tissues. These enter the
fetus where they disrupt vascular tight junctions and cross the blood brain barrier. In the
brain, this action continues especially in the rapidly growing vessels in the GM rendering
them more fragile especially when the infant is stressed by preterm birth.23 Although the
association between chorioamnionitis and PROM is well known, new evidence suggests that
inflammation/infection may be a cause rather than a result of PROM and PTL.23 Bacteria
release proteolytic enzymes that reduce the tensile strength and elasticity of the membranes.
Even when the membranes remain intact, there is evidence that infection is associated with
an increased production of cytokines known to inhibit progesterone synthesis, stimulate
prostaglandin synthesis by the amnion and chorion, and thereby incite uterine contractility
leading to preterm labor.21, 23, 24

Author Manuscript

We did not confirm our earlier findings of less LOS in infants who had DCC at birth.13 It is
well known that smaller infants are more at risk for LOS.25 There was no evidence of
confounding of the LOS results by PEC or PROM/PTL. Neither of the current metaanalyses reported significant differences in the incidence of LOS.11, 12 In the Backes review
which included only infants less than 32 weeks (n = 255), the odds ratio was 0.73 (CI 0.44,
1.20) suggesting that the larger trials with younger infants (less than 30 weeks GA) and
longer timing for delay underway in England26 and Australia may yield more definitive
answers. (Tarnow-Mordi, personal communication).
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Manuck et al report that approximately one in four preterm infants (23–34 weeks) had
neurodevelopmental impairment at two years of age.27 Possible mechanisms contributing to
better motor outcomes at 18–22 months with DCC include increased overall blood volume
(10 to 30%) offering the infant a more salutary neonatal transition and greater red cell mass
for oxygenation and iron content.1, 2 Higher levels of red blood cells provide additional iron
for the infant known to be neuroprotective at critical times in brain development as iron is
essential for the proper maturation of the pre-oligodendrocytes.28, 29 Likewise, infants with
DCC may have more hematopoietic stem cells (HSC) at birth. Infusions of HSCs soon after
injury in animal models have both neuroprotective and neurorestorative effects.30–33
Therefore, we suggest that additional iron and stem cells at birth may be the mechanisms
that offer infants with DCC an advantage.
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The differences between the subjects and the eligible women who did not enroll were
probably due to the fact that the latter were more likely to deliver sooner after admission,
allowing less time for the various procedures.
The sensitivity analyses demonstrates that the protocol violations in this study had only a
small influence on the conclusions from the primary intention to treat analyses. Thabane et
al suggest that sensitivity analyses are underused and recommend their use in every clinical
trial.18
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The major limitation of this study is the lack of a normal preterm control group. There may
be confounders of which we remain unaware. There was some loss of equipoise in our
institution but our sensitivity analyses showed that it had only a small impact on our results.
It is not possible to assess the infants’ vital signs and breathing during such a short delay.
Lastly, a delay of 30 to 45 seconds is very brief and would accordingly limit the magnitude
of the placental transfusion. In spite of our conservative protocol, even this brief delay in
cord clamping appears to benefit very preterm infants at 18–22 months corrected age.
Current studies are underway that will provide transitional support and resuscitative
measures with the cord intact for at least one to two minutes.26, 34 Further studies should
provide some answers as to the value of longer placental support during neonatal transition.
Our protocol of a brief delay in cord clamping followed by one milking of the cord is safe.
DCC may provide an advantage in reducing rates of poor motor performance at 18 to 22
months corrected age. Although there were no group differences in rates of IVH and LOS in
very preterm infants in this study, controlling for the major confounding factors of PEC and
PROM/PTL revealed their significant and opposite impact on IVH. Further studies are
needed to validate these findings.

Author Manuscript
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BPD

Bronchopulmonary dysplasia

DCC

Delayed cord clamping

GA

Gestational age

ICC

Immediate cord clamping

IVH

Intraventricular hemorrhage

LOS

Late onset sepsis

PEC

Pre-eclampsia

PTL

Preterm labor

PROM

Premature rupture of membranes
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Figure 1.

Flow chart of patients.
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Figure 2.

Logistic Regression Analyses showing Risk Factors for Motor Composite Score <85. DCC,
delayed cord clamping; ITT, intention-to-treat analysis; IVH, intraventricular hemorrhage;
BPD, bronchopulmonary dysplasia; AT, actual treatment used for the sensitivity analysis.
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Table 1

Author Manuscript

Maternal and Neonatal Demographics, Clinical, and Safety Variables
Initial Cohort

18 Month Cohort

Characteristic
DCC (n =103)

ICC (n =105)

DCC (n=82)

ICC (n=79)

28 ± 7

29 ± 6.5

29 ± 7

30 ± 6

Black

20 (20)

13 (12)

16 (20)

7 (9)

White

56 (55)

69 (66)

44 (54)

56 (71)

Other

26 (25)

23 (22)

21 (26)

16 (20)

---

---

37 (47)

24 (33)

98 ± 190*

72 ± 190

112 ± 209*

80 ± 212

Preeclampsiaa

23 (22)*

39 (37)

19 (23)

29 (37)

PROM/Preterm labora

77 (75)**

57 (54)

60 (73)**

42 (53)

Clinical Chorioamnionitis

23 (22)**

10 (9.5)

18 (22)*

6 (8)

28.3 ± 2

28.4 ± 2

28.1 ± 2

28.2 ± 2

wks

35

36

31

28

wks

68

69

51

51

Cord Clamp Time (seconds) Range,
median

32 ± 16*** (0–60)

6.6 ± 6 (1–45)

31 ± 6*** (0–60)

6.6 ± 5.2 (0–36)

Birth weight, g

1203 ± 352 (430–
1955)

1136 ± 350 (390–
2455)

1178 ± 341 (480–
1885)

1101 ± 354 (390–
2455)

52/51

62/43

42/40

47/32

1 min

6 (1–9)

6 (1–9)

6 (1–9)

6 (1–9)

5 min

8 (2–9)

8 (1–10)

8 (2–9)

8 (1–10)

<4 at 1 min,

16 (16)

20 (19)

13 (16)

14 (18)

7.4 ± 0.1*

7.3 ± 0.1

7.3 ± 0.1

7.3 ± 0.1

36.5 ± 0.8 (32–38)

36.3 ± 0.8 (33–39)

36.6 ± 0.8* (34–38)

36.3 ± 0.9 (33–38)

47.6 ± 7 (31–63)

46.4 ± 7 (32–59)

47.2 ± 7 (31–63)

46.2 ± 7 (32–59)

35 ± 8

35 ± 8

35± 8

34± 8

8 ± 2 (5–16)

8 ± 2 (4–14)

8 ± 2 (5 –16)

7.7 ± 2 (4–14)

Mother’s age (yrs)
Race / Ethnicity

Maternal Education- ≤ high school

Author Manuscript

PROM (hrs)
Reasons for preterm birth

Gestational age, wks
24 to

276

28 to

316

Author Manuscript

Male/female ratio
Apgar score, median (range)

Cord Blood Gas, Arterial
NICU Admission Temperature CO
(Range)
Initial Hematocrit (%)

Author Manuscript

1st Mean Blood Pressure
Peak bilirubin (mg/dl), First week,
Range
Mean ± SD or n (%);
*

p<0.05;
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**

p<0.01;

***

p<0.001.

a

Author Manuscript

Only PEC and PROM/PTL are mutually exclusive categories.

Author Manuscript
Author Manuscript
Author Manuscript
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Author Manuscript

Author Manuscript

p 0.01;

--

8.1 ± 2.6

7.7 ± 2.6

9.4 ± 3

4 (5)

18 (24)

91.2 ± 12

7

9 (11)

17 (22)

ICC (n=79)

--

--

--

--

3

14 (14)

25 (26)

DCC (n =97)

--

--

--

--

6

13 (12)

27 (24)

ICC (n =111)

Initial Cohort

8.1 ± 2.6

9.7 ± 2.9

7.7 ± 2.6

9.1 ± 2.4

6 (7)

23 (28)

9 (13)**
6 (9)

90 ± 13

7

9 (10)

23 (26)

ICC (n=87)

93 ± 15

3

13 (18)

20 (27)

DCC (n=74)

18 Month Cohort

Sensitivity Analyses

Bayley III Composite Motor Score; There were no differences between the groups in ROP, NEC, death or IVH, death or LOS, oxygen use at 36 weeks. Range on Bayleys (46-121) for both groups.

a

**

--

Gross Motor Score

9.4 ± 2.2

--

Fine Motor Score

--

8 (11)

--

--

92.1 ± 15

<70

--

3

13 (16)

26 (32)

14 (19)

--

Motor Scorea

6

13 (13)

23 (23)

DCC (n=82)

18 Month Cohort

<85

3

14 (14)

31 (31)

ICC (n =99)

Initial Cohort
DCC (n =100)

Deaths

Confirmed LOS

IVH – all

Outcome

Intention-to-Treat Analyses

Primary and Neonatal Outcomes By Intention-to-Treat and Sensitivity Analyses (Actual Treatment)

Author Manuscript
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